CompoAtlas

SirinMED Hyper Sensitive Enamel Protection

Natural health product licensed in Canada

Licence holder
Bukwang Pharmaceutical Co. Ltd
NPN or DIN-HM
80082864
Status
Active licence
Licence date
5 February 2018
Revision date
Not provided
Form
Dentifrice, pâte
Route of administration
Dentaire
Application type
Non traditionnelle

Oral dose analysis does not apply without an established exclusively oral route.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the source
Phosphate de calcium, hydroxyde

Source : Durapatite

19 Pour cent
Dioxyde de silicium

Source : Dioxyde de silicium

2.5 Pour cent

Non-medicinal ingredients

Rouge Allura AC, Lauryl sulfate de sodium, (p)-hydroxybenzoate de méthyle, Glycérine, Parfum, Carboxyméthylcellulose de sodium, Eau purifiée, Cocoyl Iséthionate de Sodium, Saccharinate de sodium dihydraté, Menthol

PopulationAgeQuantity per servingFrequency
AdultesNot specifiedminimum: 1 millilitre ; maximum: 5 millilitreminimum: 1 Tous les jours ; maximum: 2 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

Provides clinically shown relief from dentin hypersensitivity pain.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80082864

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line